Psoriasis shows on the skin, but it's a disease which goes a lot deeper and is linked to serious health problems. In recent years, newer targeted drugs are making a difference.

Deucravacitinib has been observed as a safe and efficacious treatment for adults with moderate to severe plaque psoriasis for up to 4 years.

There are many other types of rashes with a wide variety of causes. Treatment for a rash requires the correct diagnosis and can include medication and avoiding potential triggers.  Easily ...

Discover the early warning signs of psoriatic arthritis that could prevent permanent joint damage, plus expert advice on ...

Johnson & Johnson (J&J) has reported data from the Phase III ICONIC-LEAD trial’s subgroup analysis evaluating icotrokinra in ...

New data presented at the 2025 World Congress of Pediatric Dermatology annual meeting highlights the efficacy and safety of ...

Icotrokinra appears to be an effective treatment for adolescent patients with moderate to severe plaque psoriasis, according to a subgroup analysis of the ICONIC-LEAD study.

Protagonist and Johnson & Johnson report positive Phase 3 data on icotrokinra in adolescent plaque psoriasis, showing high ...

A growing momentum for earlier treatment of psoriasis has the potential to improve outcomes with oral therapies and biologics ...

Castor oil, enriched with essential fatty acids, vitamins, and minerals, is gaining popularity for its potential to promote hair regrowth on bald spots. Regular application of cold-pressed ...

Palmoplantar psoriasis specifically affects the palms and soles. Even so, it manifests with the same symptoms as plaque psoriasis anywhere else. Palmoplantar psoriasis, like all other types of ...

Discover whether AbbVie or Sanofi holds the edge in the global immunology market and find out which stock shows more ...